Stada’s emerging markets business will be under new management from the start of 2023, after the German generics and biosimilars giant announced the appointment of Stéphane Jacqmin to take over from Carsten Cron as head of emerging markets.
Jacqmin – who most recently served as regional head of Latin America at Sanofi Consumer Healthcare – will take the...






